Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wellgistics Health Inc ( (WGRX) ) just unveiled an announcement.
On May 1, 2026, Wellgistics, LLC and its parent Wellgistics Health, Inc. entered into a forbearance and repayment agreement with lender Marco Capital, Inc., formally acknowledging about $1.77 million in outstanding obligations under a November 22, 2024 loan. Under the deal, Marco Capital agreed to temporarily refrain from exercising certain remedies through June 15, 2026, while Wellgistics makes bi‑weekly $50,000 payments starting May 5, 2026, with interest accruing at Term SOFR plus 11.5% and a requirement that portions of future financing proceeds may be applied to repay the debt, tightening the company’s cash commitments but providing short‑term breathing room on its obligations.
The agreement also reaffirms management guaranties and includes customary covenants, events of default and reservation of rights provisions, underscoring that the company remains under close lender oversight as it works to stabilize its capital structure. This forbearance arrangement helps Wellgistics avoid immediate enforcement actions while it manages its indebtedness, but it also signals ongoing financial pressure and elevated financing costs that stakeholders will need to monitor.
More about Wellgistics Health Inc
Wellgistics Health, Inc., through its wholly owned subsidiary Wellgistics, LLC, operates in the health sector, providing products and services that are financed under a Loan and Security Agreement with Marco Capital, Inc. The company relies on structured debt financing arrangements to support its operations and manage liquidity needs in its healthcare-related business.
Average Trading Volume: 12,707,701
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.69M
For detailed information about WGRX stock, go to TipRanks’ Stock Analysis page.

